Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis

The increasing use of anticancer drugs has led to the emergence of environmental contaminants such as bleomycin (BLM), which poses significant threats to both aquatic ecosystems and human health. Bleomycin, known for its DNA-damaging properties, is extensively used in oncology. Its resistance to bio...

Full description

Saved in:
Bibliographic Details
Main Authors: Kangchen Li, Xuefang Liu, Ruilong Lu, Peng Zhao, Yange Tian, Jiansheng Li
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Ecotoxicology and Environmental Safety
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0147651324015276
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591021109673984
author Kangchen Li
Xuefang Liu
Ruilong Lu
Peng Zhao
Yange Tian
Jiansheng Li
author_facet Kangchen Li
Xuefang Liu
Ruilong Lu
Peng Zhao
Yange Tian
Jiansheng Li
author_sort Kangchen Li
collection DOAJ
description The increasing use of anticancer drugs has led to the emergence of environmental contaminants such as bleomycin (BLM), which poses significant threats to both aquatic ecosystems and human health. Bleomycin, known for its DNA-damaging properties, is extensively used in oncology. Its resistance to biodegradation, along with the limitations of conventional wastewater treatment processes, facilitates environmental accumulation from various sources, highlighting the need for effective management and treatment strategies to mitigate ecological and health risks. This study investigates the link between BLM pollution and pulmonary fibrosis, a progressive lung disease characterized by tissue scarring and loss of function. We demonstrate that BLM induces pulmonary fibrosis in mice and enhances glycolysis and fibroblast activation. Our findings also indicate that peimine, a natural compound derived from Fritillaria, suppresses fibroblast activation and ameliorates pulmonary fibrosis by inhibiting glycolysis through the PI3K/Akt/PFKFB3 signaling pathway. Taken together, this study underscores the environmental and health risks associated with the accumulation of cytostatic drugs like BLM and highlights the therapeutic potential of natural compounds such as peimine. Our results contribute to the development of novel strategies for the prevention and treatment of pulmonary fibrosis and call for better management practices to mitigate the environmental impact of cytostatic drugs.
format Article
id doaj-art-3c3a1b03db284d20b369b0c57fe93090
institution Kabale University
issn 0147-6513
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Ecotoxicology and Environmental Safety
spelling doaj-art-3c3a1b03db284d20b369b0c57fe930902025-01-23T05:25:37ZengElsevierEcotoxicology and Environmental Safety0147-65132025-01-01289117451Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysisKangchen Li0Xuefang Liu1Ruilong Lu2Peng Zhao3Yange Tian4Jiansheng Li5Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China, Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450000, ChinaCollaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China, Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450000, ChinaCollaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China, Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450000, ChinaCollaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China, Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450000, ChinaCollaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China, Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450000, China; Corresponding author.Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China, Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450000, China; Department of Respiratory Diseases, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China; Corresponding author at: Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China, Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450000, China.The increasing use of anticancer drugs has led to the emergence of environmental contaminants such as bleomycin (BLM), which poses significant threats to both aquatic ecosystems and human health. Bleomycin, known for its DNA-damaging properties, is extensively used in oncology. Its resistance to biodegradation, along with the limitations of conventional wastewater treatment processes, facilitates environmental accumulation from various sources, highlighting the need for effective management and treatment strategies to mitigate ecological and health risks. This study investigates the link between BLM pollution and pulmonary fibrosis, a progressive lung disease characterized by tissue scarring and loss of function. We demonstrate that BLM induces pulmonary fibrosis in mice and enhances glycolysis and fibroblast activation. Our findings also indicate that peimine, a natural compound derived from Fritillaria, suppresses fibroblast activation and ameliorates pulmonary fibrosis by inhibiting glycolysis through the PI3K/Akt/PFKFB3 signaling pathway. Taken together, this study underscores the environmental and health risks associated with the accumulation of cytostatic drugs like BLM and highlights the therapeutic potential of natural compounds such as peimine. Our results contribute to the development of novel strategies for the prevention and treatment of pulmonary fibrosis and call for better management practices to mitigate the environmental impact of cytostatic drugs.http://www.sciencedirect.com/science/article/pii/S0147651324015276Bleomycin pollutionPulmonary fibrosisPeimineGlycolysisPI3K/Akt/PFKFB3 Signaling
spellingShingle Kangchen Li
Xuefang Liu
Ruilong Lu
Peng Zhao
Yange Tian
Jiansheng Li
Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
Ecotoxicology and Environmental Safety
Bleomycin pollution
Pulmonary fibrosis
Peimine
Glycolysis
PI3K/Akt/PFKFB3 Signaling
title Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
title_full Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
title_fullStr Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
title_full_unstemmed Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
title_short Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
title_sort bleomycin pollution and lung health the therapeutic potential of peimine in bleomycin induced pulmonary fibrosis by inhibiting glycolysis
topic Bleomycin pollution
Pulmonary fibrosis
Peimine
Glycolysis
PI3K/Akt/PFKFB3 Signaling
url http://www.sciencedirect.com/science/article/pii/S0147651324015276
work_keys_str_mv AT kangchenli bleomycinpollutionandlunghealththetherapeuticpotentialofpeimineinbleomycininducedpulmonaryfibrosisbyinhibitingglycolysis
AT xuefangliu bleomycinpollutionandlunghealththetherapeuticpotentialofpeimineinbleomycininducedpulmonaryfibrosisbyinhibitingglycolysis
AT ruilonglu bleomycinpollutionandlunghealththetherapeuticpotentialofpeimineinbleomycininducedpulmonaryfibrosisbyinhibitingglycolysis
AT pengzhao bleomycinpollutionandlunghealththetherapeuticpotentialofpeimineinbleomycininducedpulmonaryfibrosisbyinhibitingglycolysis
AT yangetian bleomycinpollutionandlunghealththetherapeuticpotentialofpeimineinbleomycininducedpulmonaryfibrosisbyinhibitingglycolysis
AT jianshengli bleomycinpollutionandlunghealththetherapeuticpotentialofpeimineinbleomycininducedpulmonaryfibrosisbyinhibitingglycolysis